Vertex Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript
Good morning and welcome once again to Cowen and Company's hopefully only virtual health care conference. I'm Phil Nadeau, a biotech analyst here at Cowen, and it's my pleasure to moderate a fireside chat with Vertex Pharmaceuticals. Those of you who follow our research know that Vertex is one of our top large-cap picks for this year.
So we're very happy to have with us this morning President and CEO, Reshma Kewalramani. And we'll spend about 30 minutes talking through the fundamentals of the company.
Reshma, maybe you could start with giving a brief state-of-the-company overview, the biggest strengths, biggest challenges and what you think needs to happen to create shareholder value in Vertex's stock over the next year.
Good morning, Phil. It's really good to see you, and thank you for having me here today. Maybe I'll give you a thumbnail and just walk you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
